When used in children, rapid antigen tests for detecting the coronavirus do not meet accuracy criteria set by the World Health Organization and U.S. and UK device regulators, according to researchers who reviewed 17 studies of the tests. Other research appears to confirm smaller, earlier studies that suggested nursing mothers are unlikely to transmit the coronavirus in breastmilk.
LightDeck Diagnostics was awarded a $5.65 million contract from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the US Department of Health and Human Services (HHS), to develop an rapid antigen test to detect SARS-CoV-2.
The U.S. Food and Drug Administration is alerting clinical laboratory staff and healthcare providers that false positive results can occur with Covid-19 antigen tests.
Becton Dickinson is investigating reports from U.S. nursing homes that the company’s rapid coronavirus testing equipment is producing false-positive results.
Qiagen readies launch of rapid COVID-19 antigen test (Reuters) – German diagnostic test maker Qiagen on Tuesday said it planned to launch a COVID-19 antigen test that can provide results […]
Researchers are developing simpler Covid-19 diagnostic tests for use outside of labs in an effort to make mass testing available, fast and inexpensive.